Related Experiment Video
Updated: Jul 11, 2026
08:20
In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
Published on: December 30, 2016
IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity
Hans D Ochs1, Eleonora Gambineri, Troy R Torgerson
1Division of Immunology, Infectious Diseases, Rheumatology, Children's Hospital and University of Washington, 307 Westlake Ave. North, Suite 300 (CW), Seattle, WA 98109, USA. allgau@u.washington.edu
Immunologic Research
|October 6, 2007
Summary
Mutations in FOXP3 disrupt regulatory T-cell development, causing IPEX syndrome. Understanding this immune disorder offers insights into autoimmunity and potential treatments for related conditions.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- FOXP3 is crucial for regulatory T-cell development in the thymus.
- Mutations in FOXP3 lead to Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) syndrome in humans and scurfy in mice.
- IPEX syndrome is characterized by autoaggressive lymphocyte clones.
Purpose of the Study:
- To investigate the role of FOXP3 in regulatory T-cell development.
- To understand the mechanisms underlying IPEX syndrome.
- To explore potential therapeutic strategies based on IPEX research.
Main Methods:
- Analysis of FOXP3 function in T-cell development.
- Study of naturally occurring FOXP3 mutations.
- Investigation of immune dysregulation in IPEX patients and scurfy mice.
Main Results:
- FOXP3 mutations impair regulatory T-cell generation.
- This impairment results in the development of autoimmune diseases.
- Stem cell transplantation is currently the only cure for IPEX.
Conclusions:
- FOXP3 is essential for maintaining immune tolerance.
- Research into IPEX provides insights into autoimmunity, graft-versus-host disease, and cancer.
- Future studies may yield novel therapeutic approaches for immune-related disorders.
